T1	Participants 234 281	patients after abdominoperineal resection (APR)
T2	Participants 325 451	patients with rectal cancer, ulcerative colitis or rectal gastrointestinal stromal tumor, who underwent APR or proctocolectomy
T3	Participants 1010 1021	74 patients
